Flexibility for the future: key tools to scale manufacturing of different cell therapies
Modular solutions with end-to-end coverage of cell therapy workflows enable flexibility and fine-tuning for scaling up the production of different cell therapies.
It is clear that closed and automated processing reduces labor costs, simultaneously minimizing the risk of contamination and operator errors compared to manual processes. But what are the possibilities of such processing solutions, now and in the future? And how can they maintain standardization while remaining flexible enough to be customized for specific needs?
Join us for this webinar to understand how modular systems allow precise tuning of processes and can simplify scaling in production. Discover how these solutions keep options open for scaling the production of CAR-T cells, tumor-infiltrating lymphocytes (TILs) and more.
This webinar was recorded on 2 November 2023.
What will you learn?
• Examples of challenges and bottlenecks in cell therapy applications and how to overcome them
• Main characteristics and most relevant features of modular manufacturing solutions
• How the flexibility of Cytiva systems simplifies advancements in cell therapy workflows
Who may this interest?
• Process development managers looking for smart and efficient solutions to improve their process
• Scientists searching for automated yet flexible tools to advance their activities
• Manufacturing managers in need of modular, closed, and controlled instruments to make their process ready for the next step
Speakers
Nancy Coyle
Field Application Specialist, Cell and Gene Therapy, EMEA
Cytiva
Nancy has 26 years of experience in both academia and industry. Prior to joining Cytiva, she was an integral member of a process optimization and technology transfer team responsible for the development of a closed-system manufacturing process for cell therapy products.
Rubin Joshi, PhD
Field Application Specialist, Cell and Gene Therapy, EMEA
Cytiva
Rubin has been working as an Application Specialist for Cell Therapy at Cytiva for the last three years. Compounded by over 12 years in the biotech sector in R&D, he has been supporting customers in clinics, manufacturing, R&D and education to develop cGMP-compliant manufacturing processes and novel cell therapeutic applications. Rubin also manages a cell therapy lab at Testa Center (Uppsala, Sweden) for live demos and fostering collaborative ventures in cell therapy.
In association with
